IV tissue plasminogen activator use in acute stroke: experience from a statewide registry.
about
Management of Postthrombolysis Hemorrhagic and Orolingual Angioedema ComplicationsIntravenous anakinra can achieve experimentally effective concentrations in the central nervous system within a therapeutic time window: results of a dose-ranging studyStroke preparedness in children: translating knowledge into behavioral intent: a systematic review and meta-analysis.Early identification and delay to treatment in myocardial infarction and stroke: differences and similarities.Impact of a multimedia campaign to increase intention to call 9-1-1 for stroke symptoms, upstate New York, 2006-2007Barriers and disparities in emergency medical services 911 calls for stroke symptoms in the United States adult population: 2009 BRFSS Survey.The role of ethnicity, sex, and language on delay to hospital arrival for acute ischemic strokeStroke in women: disparities and outcomes.Gender differences in acute stroke treatment: the University of California San Diego experience.Attitudes and beliefs of Michigan emergency physicians toward tissue plasminogen activator use in stroke: baseline survey results from the INcreasing Stroke Treatment through INteractive behavioral Change Tactic (INSTINCT) trial hospitals.Emergency department arrival times, treatment, and functional recovery in women with acute ischemic strokeDesign, data analysis and sampling techniques for clinical research.Knowledge of thrombolytic therapy for acute ischemic stroke among community residents in western urban China.Gender differences in the functional recovery after acute stroke.Gender differences in 1-year clinical characteristics and outcomes after stroke: results from the China National Stroke RegistryAccuracy of identifying acute stroke admissions in a Michigan Stroke Registry.Thymosin beta4: a candidate for treatment of stroke?Knowledge of Community General Practitioners and Nurses on Pre-Hospital Stroke Prevention and Treatment in Chongqing, China.Neighborhood Influences on Emergency Medical Services Use for Acute Stroke: A Population-Based Cross-sectional Study.Safety of thrombolysis in acute ischemic stroke: a review of complications, risk factors, and newer technologies.Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomesMRI Dynamically Evaluates the Therapeutic Effect of Recombinant Human MANF on Ischemia/Reperfusion Injury in Rats.Systematic review of stroke thrombolysis service configuration.Thrombolysis treatment for acute stroke: issues of efficacy and utilization in women.Historical perspective and future direction of thrombolysis research: the re-discovery of plasmin.Safety of intravenous thrombolysis for acute ischemic stroke in specific conditions.Point-of-Care-Testing in Acute Stroke Management: An Unmet Need Ripe for Technological Harvest.Individual and System Contributions to Race and Sex Disparities in Thrombolysis Use for Stroke Patients in the United States.Sex differences in stroke: Review of current knowledge and evidence.Study design and population pharmacokinetic analysis of a phase II dose-ranging study of interleukin-1 receptor antagonist.Emerging temporal trends in tissue plasminogen activator use: Results from the BASIC project.Patient delay in acute stroke response.Knowledge of stroke warning symptoms and intended action in response to stroke in Spain: a nationwide population-based study.Safety of off-label stroke treatment with tissue plasminogen activator.Thrombolytic therapy for acute ischaemic stroke: what can we do to improve outcomes?Connecting to the future--the promise of telecare.The Influence of Sex in Stroke Thrombolysis: A Systematic Review and Meta-Analysis.Practice Patterns and Barriers for Intravenous Thrombolysis: A Survey of Neurologists in Saudi Arabia.
P2860
Q26796470-288C3D73-3D07-42D1-BA22-D19258506AB4Q28287860-0AF546BF-30CC-490C-8A19-7F298BB6255BQ30151101-95A12174-BCA3-4392-9A98-DAF9AD8423C3Q33684081-C4DE05C7-BEB0-42E9-A167-C5EF048EF5B3Q33702063-B29216AB-3831-4675-94A3-E4B4EE81B343Q33706124-2F1AA50E-9F96-4758-B802-D65E1E498432Q33814647-C445B5B8-408B-4857-B9EE-5F0E3C0C2AB2Q33819202-87578AC5-1797-4E04-9DA3-F69100D2B512Q34023228-712C1926-AF1D-4516-A0C9-EB83BC13C779Q34111171-EA206AA8-9F25-4842-B185-647087F274B8Q34132281-35519ADD-704F-4D48-A92D-D7A4885CEC8DQ34161923-521A483D-866B-4DD3-8F53-1599DCB9EC7BQ34184174-747F6D9E-5E64-4C13-B434-406024D7D39DQ34508156-723D9EC6-FAF9-4653-B03F-99B131E58F6CQ34590096-F0E3A7E6-D14E-40F7-A13B-E3206CEA2D5FQ35011747-69ECA20B-EAE4-45F0-95B0-D64BA4E060A8Q35135176-6382CEE4-B7BA-4D42-85CD-5D28FCA13CE9Q35780667-C93DEB2E-DAD1-409E-A70F-A7EEBC664CB2Q36625982-B8C080F7-B28D-4FD4-952B-53079A09DF6FQ37052824-D24265B5-7054-402F-B07E-F305C26ADE16Q37149840-15348AB8-3276-4238-AD3E-56B7D34ECDF3Q37286459-90514B7E-CC56-4F01-BAB1-D3527A4CA4E9Q37390717-E0E5B0B3-05C6-498A-A8A4-3DEEB324AB6FQ37879682-AF80B1FA-45FA-4C97-B05B-52CF25756898Q37903963-304154C8-9121-41F3-86FC-D8610398B780Q38407477-C5F3A64B-98A0-4056-B2C1-8A4987A88783Q38644674-27F381C2-3F4D-4DE0-9C0E-6D1F843F0F89Q38914021-1064C231-FD47-49A9-A296-A02E92D52FC7Q38999149-E34BCD89-8304-40FC-8CC3-F90A2E2BA321Q40420576-9499F1FC-B673-494F-8940-AC8AF925B15FQ40524726-F3017FB1-1421-4C5E-90A9-59F4C2EF73FDQ43135255-75BC74FD-25F6-4E5C-892A-BA321FE2CB66Q45795801-44407608-39EC-4A8E-9B9F-3C4B72277D7CQ46575238-9B763B77-9CFE-402F-9C21-F5B6AC641485Q48393871-E39ECDA8-104E-4727-AADE-A3BDF85959FFQ51612767-6FEA1146-669A-4969-8F2E-AD511468E791Q52599324-BFB5BCF6-E0B3-42F5-9930-E162107D940FQ54956853-09BD2C33-F6D6-4A23-8033-CAF7B1DFB50E
P2860
IV tissue plasminogen activator use in acute stroke: experience from a statewide registry.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
IV tissue plasminogen activato ...... nce from a statewide registry.
@en
IV tissue plasminogen activato ...... nce from a statewide registry.
@nl
type
label
IV tissue plasminogen activato ...... nce from a statewide registry.
@en
IV tissue plasminogen activato ...... nce from a statewide registry.
@nl
prefLabel
IV tissue plasminogen activato ...... nce from a statewide registry.
@en
IV tissue plasminogen activato ...... nce from a statewide registry.
@nl
P2093
P1433
P1476
IV tissue plasminogen activato ...... nce from a statewide registry.
@en
P2093
A J Mullard
B S Jacobs
G L Birbeck
M J Reeves
Paul Coverdell National Acute Stroke Registry Michigan Prototype Investigators
R U Kothari
S L Hickenbottom
P304
P356
10.1212/01.WNL.0000196478.77152.FC
P407
P577
2006-02-01T00:00:00Z